Brief: Adial Pharmaceuticals Regains Full Compliance With Nasdaq Listing Requirement

Azora Therapeutics

24/02/2026 14:06

Feb 24 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:

ADIAL PHARMACEUTICALS REGAINS FULL COMPLIANCE WITH NASDAQ LISTING REQUIREMENT

Source text: ID:nGNX1T04bW

Further company coverage: ADIL.O

 (((( Reuters.briefs@thomsonreuters.com ;));))